Business Description
Hester Biosciences Ltd
ISIN : INE782E01017
Compare
Compare
Traded in other countries / regions
524669.India IPO Date
1994-10-31Description
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.15 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.81 | |||||
| Debt-to-EBITDA | 3.82 | |||||
| Interest Coverage | 5.64 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.13 | |||||
| Beneish M-Score | -2.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.4 | |||||
| 3-Year EBITDA Growth Rate | -5.7 | |||||
| 3-Year EPS without NRI Growth Rate | -20.9 | |||||
| 3-Year FCF Growth Rate | 11.1 | |||||
| 3-Year Book Growth Rate | 8.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.93 | |||||
| 9-Day RSI | 20.52 | |||||
| 14-Day RSI | 29.82 | |||||
| 6-1 Month Momentum % | -6.63 | |||||
| 12-1 Month Momentum % | 55.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 259.97 | |||||
| Days Sales Outstanding | 105.88 | |||||
| Days Payable | 94.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.26 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| 3-Year Dividend Growth Rate | 6.6 | |||||
| Forward Dividend Yield % | 0.26 | |||||
| 5-Year Yield-on-Cost % | 0.27 | |||||
| Shareholder Yield % | 1.79 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.55 | |||||
| Operating Margin % | 16.93 | |||||
| Net Margin % | 7.52 | |||||
| FCF Margin % | 7.6 | |||||
| ROE % | 8.04 | |||||
| ROA % | 3.49 | |||||
| ROIC % | 5.86 | |||||
| 3-Year ROIIC % | -5.04 | |||||
| ROC (Joel Greenblatt) % | 8.75 | |||||
| ROCE % | 8.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 80.88 | |||||
| PE Ratio without NRI | 80.88 | |||||
| Shiller PE Ratio | 56.75 | |||||
| PS Ratio | 6.09 | |||||
| PB Ratio | 6.39 | |||||
| Price-to-Tangible-Book | 6.47 | |||||
| Price-to-Free-Cash-Flow | 81.2 | |||||
| Price-to-Operating-Cash-Flow | 40.04 | |||||
| EV-to-EBIT | 44.66 | |||||
| EV-to-EBITDA | 33.61 | |||||
| EV-to-Revenue | 6.88 | |||||
| EV-to-FCF | 90.51 | |||||
| Price-to-Projected-FCF | 36.72 | |||||
| Price-to-Graham-Number | 4.82 | |||||
| Earnings Yield (Greenblatt) % | 2.24 | |||||
| FCF Yield % | 1.23 | |||||
| Forward Rate of Return (Yacktman) % | -3.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hester Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,121.97 | ||
| EPS (TTM) (₹) | 28.012 | ||
| Beta | 1.25 | ||
| Volatility % | 56.76 | ||
| 14-Day RSI | 29.82 | ||
| 14-Day ATR (₹) | 65.939107 | ||
| 20-Day SMA (₹) | 2390.1425 | ||
| 12-1 Month Momentum % | 55.43 | ||
| 52-Week Range (₹) | 1292.9 - 3375.45 | ||
| Shares Outstanding (Mil) | 8.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hester Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hester Biosciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hester Biosciences Ltd Frequently Asked Questions
What is Hester Biosciences Ltd(BOM:524669)'s stock price today?
The current price of BOM:524669 is ₹2265.70. The 52 week high of BOM:524669 is ₹3375.45 and 52 week low is ₹1292.90.
When is next earnings date of Hester Biosciences Ltd(BOM:524669)?
The next earnings date of Hester Biosciences Ltd(BOM:524669) is 2025-01-31 Est..
Does Hester Biosciences Ltd(BOM:524669) pay dividends? If so, how much?
The Dividend Yield %  of Hester Biosciences Ltd(BOM:524669) is 0.26% (As of Today), Highest Dividend Payout Ratio of Hester Biosciences Ltd(BOM:524669) was 0.37. The lowest was 0.14. And the median was 0.21. The  Forward Dividend Yield % of Hester Biosciences Ltd(BOM:524669) is 0.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers